Cancer ecosystems: A dynamic interplay across scales.
2/5 보강
OpenAlex 토픽 ·
Mathematical Biology Tumor Growth
Zoonotic diseases and public health
Health, Environment, Cognitive Aging
Tumors evolve within complex, adaptive ecosystems that operate across spatial, temporal, and systemic scales.
APA
Daniela F. Quail, Johanna A. Joyce (2026). Cancer ecosystems: A dynamic interplay across scales.. Cell, 189(8), 2441-2463. https://doi.org/10.1016/j.cell.2026.03.003
MLA
Daniela F. Quail, et al.. "Cancer ecosystems: A dynamic interplay across scales.." Cell, vol. 189, no. 8, 2026, pp. 2441-2463.
PMID
41997130 ↗
Abstract 한글 요약
Tumors evolve within complex, adaptive ecosystems that operate across spatial, temporal, and systemic scales. Within each tumor microenvironment, numerous diverse cell populations assemble into specialized niches that are continually shaped by systemic physiology, environmental inputs, and therapeutic pressure. Beyond the local microenvironment, cancer progression is governed by the host macroenvironment, where intrinsic biological determinants intersect with modifiable factors to collectively impact physiological fitness and tissue resilience. Here, we propose a multi-scale framework that unites tumor biology with organismal physiology and reframes therapy from eliminating malignant cells in isolation to reprogramming the cellular, vascular, and systemic networks that sustain disease. We highlight emerging approaches that aim to restore physiological equilibrium, spanning from spatial multi-omics and AI-driven pathology to immune-vascular normalization and physiological conditioning. Together, these dimensions define an integrative vision for precision oncology that bridges discovery and intervention to achieve durable and ultimately curative cancer therapy.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.